During the past decade, State Research Institute of CIrculation Pathology conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 4 clinical trials were completed, i.e. on average, 12.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "State Research Institute of CIrculation Pathology" #1 sponsor was "Meshalkin Research Institute of Pathology of Circulation" with 73 trials, followed by "Università Vita-Salute San Raffaele" with 2 trials sponsored, "Biosense Webster, Inc." with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Cardiovascular Research Society, Greece" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "State Research Institute of CIrculation Pathology" #1 collaborator was "Medtronic Bakken Research Center" with 2 trials as a collaborator, "BUPA Foundation" with 1 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "NHS Health Technology Assessment Programme" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "State Research Institute of CIrculation Pathology" are "Atrial Fibrillation" (21 trials), "Coronary Artery Disease" (8 trials), "Cardiac Surgery" (7 trials), "Ischemic Heart Disease" (6 trials) and "Paroxysmal Atrial Fibrillation" (6 trials). Many other conditions were trialed in "State Research Institute of CIrculation Pathology" in a lesser frequency.

Most popular intervention types in "State Research Institute of CIrculation Pathology" are "Procedure" (55 trials), "Drug" (28 trials), "Device" (18 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Coronary artery bypass grafting" (4 trials), "Pulmonary vein isolation" (4 trials), "ILR implantation" (3 trials), "Implantable loop recorder" (3 trials) and "Warfarin" (3 trials). Other intervention names were less common.

The vast majority of trials in "State Research Institute of CIrculation Pathology" are 82 trials for "All" genders.

Currently, there are NaN active trials in "State Research Institute of CIrculation Pathology". 1 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in State Research Institute of CIrculation Pathology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in State Research Institute of CIrculation Pathology, 6 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 25 trials that are defined as “Not Applicable".